http://www.drugdiscoverytoday.com/ Copyright Elsevier Ltd Intuitiv Ltd (www.intuitiv.net) 2010-09-10T14:09Z http://www.drugdiscoverytoday.com/ http://www.drugdiscoverytoday.com/_common/img/template/ddt/site-logo.gif http://www.drugdiscoverytoday.com/webinar/73/metabolomics-a-novel-tool-for-understanding-the-earlystage-mechanistic-underpinnings-of-drug-action-and-safety In association with Matabolon. This presentation demonstrated the utility of metabolomics in drug safety research through a case study done in collaboration with Teva Pharmaceutical Industries Ltd. 2009-06-30 http://www.drugdiscoverytoday.com/webinar/73/metabolomics-a-novel-tool-for-understanding-the-earlystage-mechanistic-underpinnings-of-drug-action-and-safety http://www.drugdiscoverytoday.com/webinar/69/aequorin-bioluminescence-assays-a-paradigm-shift 2009-08-24 http://www.drugdiscoverytoday.com/webinar/69/aequorin-bioluminescence-assays-a-paradigm-shift http://www.drugdiscoverytoday.com/webinar/128/the-renaissance-of-clinical-biochemistry-diagnostic-biomarker-discovery-by-targeted-metabolomics Metabolomics, i.e. the systematic identification and quantitation of marker metabolites in a given compartment, cell, tissue or body fluid, is increasingly recognized as the most relevant approach to depicting the functional end-points of physiological and pathophysiological processes. Yet, a reliable and standardized technology platform rendering metabolomics applicable to routine diagnostics has not been in place so far. 2010-02-22 http://www.drugdiscoverytoday.com/webinar/128/the-renaissance-of-clinical-biochemistry-diagnostic-biomarker-discovery-by-targeted-metabolomics